GB201808507D0 - Dosage Regime - Google Patents

Dosage Regime

Info

Publication number
GB201808507D0
GB201808507D0 GBGB1808507.6A GB201808507A GB201808507D0 GB 201808507 D0 GB201808507 D0 GB 201808507D0 GB 201808507 A GB201808507 A GB 201808507A GB 201808507 D0 GB201808507 D0 GB 201808507D0
Authority
GB
United Kingdom
Prior art keywords
dosage regime
regime
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808507.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1808507.6A priority Critical patent/GB201808507D0/en
Publication of GB201808507D0 publication Critical patent/GB201808507D0/en
Priority to EP19729452.3A priority patent/EP3796942A1/en
Priority to PCT/EP2019/063262 priority patent/WO2019224275A1/en
Priority to US17/057,486 priority patent/US20220111065A1/en
Priority to CN201980034789.3A priority patent/CN113286616A/en
Priority to SG11202010469QA priority patent/SG11202010469QA/en
Priority to CA3098103A priority patent/CA3098103A1/en
Priority to JP2020564541A priority patent/JP2021524449A/en
Priority to KR1020207037115A priority patent/KR20210016562A/en
Priority to MX2020012418A priority patent/MX2020012418A/en
Priority to BR112020023846-5A priority patent/BR112020023846A2/en
Priority to AU2019272838A priority patent/AU2019272838A1/en
Priority to IL278819A priority patent/IL278819A/en
Priority to PH12020500670A priority patent/PH12020500670A1/en
Ceased legal-status Critical Current

Links

GBGB1808507.6A 2018-05-23 2018-05-23 Dosage Regime Ceased GB201808507D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1808507.6A GB201808507D0 (en) 2018-05-23 2018-05-23 Dosage Regime
AU2019272838A AU2019272838A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
CA3098103A CA3098103A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
KR1020207037115A KR20210016562A (en) 2018-05-23 2019-05-22 Molecular adjuvant
US17/057,486 US20220111065A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
CN201980034789.3A CN113286616A (en) 2018-05-23 2019-05-22 Molecular adjuvant
SG11202010469QA SG11202010469QA (en) 2018-05-23 2019-05-22 Molecular adjuvant
EP19729452.3A EP3796942A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
JP2020564541A JP2021524449A (en) 2018-05-23 2019-05-22 Molecular adjuvant
PCT/EP2019/063262 WO2019224275A1 (en) 2018-05-23 2019-05-22 Molecular adjuvant
MX2020012418A MX2020012418A (en) 2018-05-23 2019-05-22 Molecular adjuvant.
BR112020023846-5A BR112020023846A2 (en) 2018-05-23 2019-05-22 MOLECULAR ADJUVANT
IL278819A IL278819A (en) 2018-05-23 2020-11-18 Molecular adjuvant
PH12020500670A PH12020500670A1 (en) 2018-05-23 2020-11-19 Molecular adjuvant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808507.6A GB201808507D0 (en) 2018-05-23 2018-05-23 Dosage Regime

Publications (1)

Publication Number Publication Date
GB201808507D0 true GB201808507D0 (en) 2018-07-11

Family

ID=62812162

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1808507.6A Ceased GB201808507D0 (en) 2018-05-23 2018-05-23 Dosage Regime

Country Status (1)

Country Link
GB (1) GB201808507D0 (en)

Similar Documents

Publication Publication Date Title
IL276232A (en) Pharmaceutical compounds
GB2569961B (en) Pharmaceutical
GB2572126B (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
GB201810245D0 (en) Pharmaceutical compounds
GB201713653D0 (en) Dosage regimen
IL275708A (en) G1t38 superior dosage regimes
IL283900A (en) Pharmaceutical combinations
GB201810239D0 (en) Pharmaceutical compounds
GB201819961D0 (en) Pharmaceutical compounds
IL277334A (en) Pharmaceutical combinations
GB201819960D0 (en) Pharmaceutical compounds
IL279334A (en) Pharmaceutical combinations
GB201801562D0 (en) Pharmaceutical compounds
GB201800378D0 (en) Pharmaceutical compounds
IL269169A (en) Novel dosage form
GB201816369D0 (en) Pharmaceutical compounds
GB201607548D0 (en) Solid dosage form
GB201812049D0 (en) Pesticidal dosage form
GB201808507D0 (en) Dosage Regime
GB201808473D0 (en) Dosage regime
GB201808101D0 (en) Dosage regime
GB201803298D0 (en) Dosage regime
GB201802679D0 (en) Dosage regime
GB201720544D0 (en) Dosage regime

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)